Related Experiment Video

Updated: Aug 17, 2026

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
15:43

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes

Published on: January 7, 2013

The sensitivity of renal cell carcinoma cells to interferon alpha correlates with p53-induction and involves Bax

S Wittnebel1, A Jalil, J Thiery

  • 1INSERM Unité 487, Cytokines et immunologie des tumeurs humaines, Institut Gustave-Roussy, 39 rue Camille-Desmoulins, 94805 Villejuif Cedex.

European Cytokine Network
|June 9, 2005
PubMed

Insights

Interferon alpha (IFN-alpha) treatment affects p53 expression differently in renal cell carcinoma (RCC) cells. Enhanced p53 and Bax activity in RCC7 cells suggests a role in controlling sensitivity to IFN-alpha therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Interferon alpha (IFN-alpha) is an approved treatment for metastatic renal cell carcinoma (RCC).
  • The precise mechanisms of IFN-alpha action in RCC remain unclear.
  • The tumor suppressor protein p53's role in IFN-alpha response is emerging in other cancers.

Purpose of the Study:

  • To investigate the role of p53 in the cellular response to IFN-alpha in two distinct RCC cell lines.
  • To determine if p53 expression influences RCC cell sensitivity to IFN-alpha.
  • To explore downstream molecular events related to p53 activation.

Main Methods:

  • Treatment of two human RCC cell lines (RCC5 and RCC7) with IFN-alpha.
  • Analysis of p53 expression levels.
  • Assessment of cell viability and cell death following IFN-alpha and gamma-irradiation.
  • Evaluation of Bcl-2 and Bax expression and Bax localization using intracellular staining.

Main Results:

  • IFN-alpha significantly increased p53 expression in RCC7 cells but not in RCC5 cells.
  • Cell viability was unaffected by IFN-alpha alone in both cell lines.
  • Gamma-irradiation induced greater cell death in IFN-alpha-pretreated RCC7 cells compared to RCC5 cells.
  • IFN-alpha and gamma-irradiation induced a shift of Bax to the mitochondria in RCC7 cells, preceding cell death.

Conclusions:

  • p53 expression is differentially regulated by IFN-alpha in RCC cell lines.
  • The p53 pathway, particularly the mitochondrial translocation of Bax, may play a crucial role in mediating RCC sensitivity to IFN-alpha.
  • These findings suggest potential therapeutic strategies targeting the p53-Bax axis in RCC.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...